AIDS Therapy 2nd Revised edition [Hardback]

New edition of a text that provides guidance on the diagnosis and therapy of disorders associated with AIDS. The 67 chapters cover topics including pathogens; organ-based syndromes; individual drugs used for therapy; antiretroviral, immune-based and alternative therapies; administration, interactions, and therapy management. New information includes new fusion inhibitors such as T-20, the protease inhibitor Tenofovir Disoproxil Fumerate, and advances in the use of resistance testing to manage antiretroviral therapy. Tables summarize data on clinical viruses, drug interactions, side effects, results of clinical studies, antiretroviral therapy, therapy for opportunistic infections, and more. Edited by Dolin (Harvard Medical School), Henry Masur (National Institutes of Health) and Michael S. Saag (U. of Alabama). Annotation c. Book News, Inc., Portland, OR (booknews.com)

This comprehensive reference is an up-to-date source of concise guidance on the diagnosis and therapy of disorders associated with AIDS. Discussions encompass pathogens, organ-based syndromes, and the individual drugs used for therapy. Antiretroviral, immune-based, and alternative therapies are all covered, and information is provided on administration, interactions, and therapy management. Thoroughly revised and updated, this second edition contains the latest information on new drugs and new approaches to the management of HIV/AIDS.

• Includes management algorithms in the syndrome chapters in Section VII.

• Features easy-to-access tables that summarize important information on clinical viruses, drug interactions, side effects, results of clinical studies, antiretroviral therapy, therapy for opportunistic infections, and more.

• Offers helpful appendices that list HIV-related Internet resources and provide adult dosage guidelines for antiretroviral therapies.

• Covers new fusion inhibitors such as T-20.
• Provides up-to-date information on the protease inhibitor Tenofovir Disoproxil Fumarate.
• Contains the latest advances in the use of resistance testing to manage antiretroviral therapy.